Stockscreener 앱 받기
10.50
32.82%
-5.13
시간 외 거래:
10.29
-0.21
-2.00%
전일 마감가:
$15.63
열려 있는:
$9.19
하루 거래량:
16.76M
Relative Volume:
6.18
시가총액:
$654.06M
수익:
$15.75M
순이익/손실:
$-235.15M
주가수익비율:
-2.394
EPS:
-4.386
순현금흐름:
$-154.09M
1주 성능:
-57.08%
1개월 성능:
-57.49%
6개월 성능:
-38.27%
1년 성능:
-20.15%
1일 변동 폭
$8.96
$11.09
1주일 범위
$8.96
$25.13
52주 변동 폭
$7.76
$71.50
Uniqure N V Stock (QURE) Company Profile
명칭
Uniqure N V
전화
1-339-970-7000
주소
PAASHEUVELWEG 25A, AMSTERDAM
Compare QURE vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QURE
Uniqure N V
|
10.50 | 973.62M | 15.75M | -235.15M | -154.09M | -4.386 |
|
VRTX
Vertex Pharmaceuticals Inc
|
486.03 | 126.21B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
790.81 | 82.64B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
756.76 | 47.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.07 | 44.15B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
314.36 | 35.08B | 4.98B | 69.60M | 525.67M | 0.5198 |
Uniqure N V Stock (QURE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-28 | 개시 | Barclays | Equal Weight |
| 2025-11-04 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-08-14 | 업그레이드 | Mizuho | Neutral → Outperform |
| 2025-04-01 | 재개 | Chardan Capital Markets | Buy |
| 2024-12-10 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-10-10 | 재개 | Raymond James | Outperform |
| 2024-02-29 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-12-19 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2022-03-17 | 업그레이드 | UBS | Neutral → Buy |
| 2021-06-15 | 개시 | BTIG Research | Buy |
| 2021-05-21 | 개시 | UBS | Neutral |
| 2021-04-26 | 재개 | Credit Suisse | Outperform |
| 2021-04-01 | 업그레이드 | Mizuho | Neutral → Buy |
| 2021-01-07 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-11-24 | 개시 | H.C. Wainwright | Buy |
| 2020-11-11 | 개시 | Berenberg | Buy |
| 2020-11-09 | 개시 | Jefferies | Buy |
| 2020-11-04 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-10-23 | 개시 | RBC Capital Mkts | Outperform |
| 2020-08-25 | 개시 | Raymond James | Strong Buy |
| 2020-07-31 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-06-25 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2020-06-25 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-06-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2019-12-03 | 개시 | Cowen | Outperform |
| 2019-12-03 | 개시 | Goldman | Buy |
| 2019-11-05 | 개시 | Credit Suisse | Outperform |
| 2019-10-11 | 개시 | Stifel | Buy |
| 2019-09-25 | 개시 | Bernstein | Outperform |
| 2019-09-12 | 개시 | Mizuho | Buy |
| 2019-07-30 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-07-08 | 재확인 | Cantor Fitzgerald | Overweight |
| 2019-04-12 | 개시 | Piper Jaffray | Overweight |
| 2019-03-29 | 개시 | Robert W. Baird | Outperform |
모두보기
Uniqure N V 주식(QURE)의 최신 뉴스
QURE INVESTOR ALERT: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 - Morningstar
uniQure (QURE) Shares Affected by FDA Commentary - GuruFocus
Stifel comments on uniQure shares after FDA commissioner remarks By Investing.com - Investing.com India
uniQure (QURE) Faces Investor Concerns Amid FDA Commentary - GuruFocus
uniQure (NASDAQ:QURE) Shares Gap DownShould You Sell? - MarketBeat
uniQure down on FDA chief's comments (update) (QURE:NASDAQ) - Seeking Alpha
Portnoy Law Firm Announces Class Action on Behalf of uniQure N.V. Investors - GlobeNewswire
uniQure (QURE) Shares Plunge as FDA Casts Doubt on AMT-130 Approval - GuruFocus
uniQure N.V. Stock Alert: QURE Stockholders Who Lost Money in the Company Should Contact Robbins LLP for Information on How to Recover Their Losses - PR Newswire
UniQure stock tumbles on FDA comments about gene therapy trial - Investing.com
INVESTOR REMINDER: Berger Montague Notifies uniQure N.V. (QURE) Investors of a Class Action Lawsuit and Deadline - marketscreener.com
UNIQURE N.V. (QURE) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds uniQure N.V. Investors of ... - Bluefield Daily Telegraph
UNIQURE N.V. (QURE) SHAREHOLDER ALERT Bernstein Liebhard - GlobeNewswire
uniQure Shareholder Alert: ClaimsFiler Reminds Investors - GlobeNewswire
UNIQURE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Encourages uniQure N.V. ... - Bluefield Daily Telegraph
UNIQURE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
UNIQURE CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Encourages uniQure N.V. Stockholders with Large Losses to Contact the Firm - GlobeNewswire Inc.
QURE CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds - GlobeNewswire
QURE CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 (2026-02-25) - Seeking Alpha
uniQure N.V. (QURE) Class Action Lawsuit Filed by Kessler - GlobeNewswire
UNIQURE N.V. (QURE) DEADLINE ALERT Bernstein Liebhard LLP Reminds uniQure N.V. Investors of Upcoming Deadline - ACCESS Newswire
uniQure N.V. $QURE Shares Sold by JPMorgan Chase & Co. - MarketBeat
uniQure N.V. Securities Fraud Class Action Result of FDA - GlobeNewswire
Corcept Therapeutics Incorporated Securities Fraud Class Action Result of FDA Approval Issues and 50% Stock Decline - GlobeNewswire Inc.
BellRing Brands, Inc. Securities Fraud Class Action Result of Inventory Issues and 52% Stock Decline - GlobeNewswire Inc.
QURE Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages QURE Investors with Losses to Contact the Firm - PR Newswire
QURE UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 - TMX Newsfile
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
QURE INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that uniQure N.V. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
The Gross Law Firm Reminds uniQure Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 13, 2026QURE - Morningstar
Wolfe Research Initiates Coverage on uniQure (QURE) with 'Peer P - GuruFocus
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Wolfe Research Initiates Coverage of uniQure N.V. (QURE) with Peer Perform Recommendation - Nasdaq
5 Analysts Assess uniQure: What You Need To Know - Benzinga
Holzer & Holzer, LLC Reminds QURE Investors of the April - GlobeNewswire
ROSEN, A TOP RANKED LAW FIRM, Encourages uniQure N.V. - GlobeNewswire
Shareholders that lost money on uniQure N.V.(QURE) Urged to - GlobeNewswire
uniQure N.V. (QURE) Investors Have Opportunity to Lead Securities Fraud Class Action LawsuitContact Kessler Topaz Meltzer & Check, LLP - FinancialContent
Bronstein, Gewirtz & Grossman LLC Urges uniQure N.V. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
Quarterly Risk: Can uniQure NV continue delivering strong returns - baoquankhu1.vn
uniQure to Announce 2025 Financial Results - The Manila Times
uniQure N.V. to Report Q4 and Full Year 2025 Financial Results on March 2, 2026 - Quiver Quantitative
UniQure N.V. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsQURE - marketscreener.com
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit – Company Announcement - Financial Times
User - The Chronicle-Journal
QURE STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that uniQure N.V. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
uniQure (NASDAQ:QURE) Stock Price Down 5.8% – Should You Sell? - Defense World
Will uniQure N.V. stock recover faster than marketPortfolio Performance Summary & Risk Adjusted Buy and Sell Alerts - mfd.ru
Avoro Capital Advisors LLC Increases Stake in uniQure NV - GuruFocus
uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V.QURE - Sahm
RTW INVESTMENTS, LP Reduces Stake in uniQure NV - GuruFocus
Uniqure N V (QURE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.90%
2.73%
자본화:
|
볼륨(24시간):